Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Seth Anderson

Physician Assistant Winston Salem, NC Physician Assistant

NPI 1003290263 CMS profile 10767985

3001 Lyndhurst Ave, Winston Salem, NC 27103

Open in the dashboard

General payments

$3,330

182 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Seth Anderson of Winston Salem, NC is reported in the CMS Open Payments database as having received $3,330 across 182 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $493 25
2024 General $841 41
2023 General $652 34
2022 General $732 44
2021 General $612 38

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Seth Anderson
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Seth Anderson were reported at $493. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Seth Anderson Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $612 $132 $37–$438 $132
2022 $732 $155 $48–$522 $149
2023 $652 $167 $52–$557 $160
2024 $841 $178 $55–$600 $164
2025 $493 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. GlaxoSmithKline, LLC. $405 28 payments
  2. Boehringer Ingelheim Pharmaceuticals, Inc. $348 17 payments
  3. AstraZeneca Pharmaceuticals LP $326 20 payments
  4. Regeneron Healthcare Solutions, Inc. $258 13 payments
  5. United Therapeutics Corporation $226 12 payments
  6. Gilead Sciences, Inc. $174 9 payments
  7. Merck Sharp & Dohme Corporation $158 10 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $156 8 payments
  9. Mallinckrodt Hospital Products Inc. $130 6 payments
  10. Relypsa, Inc. $114 4 payments
  11. Other $1,035 55 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,330 182 payments
Products named General payments · program years 2021–2025
  1. TRELEGY ELLIPTA $341 24 payments
  2. SPIRIVA RESPIMAT $283 15 payments
  3. STIOLTO RESPIMAT $166 9 payments
  4. ZERBAXA $158 10 payments
  5. YUPELRI $143 8 payments
  6. OFEV $134 6 payments
  7. DUPIXENT Immunology And Inflammation $132 7 payments
  8. ACTHAR $130 6 payments
  9. DUPIXENT Inflammation And Immunology $125 6 payments
  10. BREZTRI $118 9 payments
  11. Other $2,359 127 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

182 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record